CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,243 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01734434
NCT01734434N/ACompleted

A Multicenter, Observational Study to Identify Factors That Influence Access of Pregnant Women and Their Infants to Their Local Healthcare Systems

Novartis Vaccines·observational·Posted Nov 27, 2012·Updated Dec 11, 2018

In Brief

An observational study for Pregnancy, Newborn Health. Completed, enrolled 3,243 participants across 10 sites in 4 countries.

Detailed Summary

This study collected information regarding the factors that might influence access of pregnant women to the local healthcare system. The main visits of the study screened \& enrollment, delivery and 90 day infant follow-up. Data were collected mainly from questionnaires administered to pregnant women at these visits. The questionnaires contained the following standard questions which were asked at each visit, in addition to some visit-specific questions related to delivery and health status of infants up to 90 days of age. The standard questions related to the following aspects: * Logistics of transportation to the study site (type, time it takes, cost incurred) * Accessibility to a telephone/cell phone * Provisions of alternative child care during site visits if there are other children under the subject's care

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDominican Republic, Mozambique, Panama, South Africa
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 27, 2012
Enrollment StartNov 1, 2012
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.6 years ago